Skip to main content
Canna~Fangled Abstracts

Endocannabinoid Mechanisms Influencing Nausea.

By November 6, 2015No Comments
 2015;125:127-62. doi: 10.1016/bs.irn.2015.09.001. Epub 2015 Nov 6.

Abstract

PM 1aOne of the first recognized medical uses of Δ(9)-tetrahydrocannabinol was treatment of chemotherapy-induced nausea and vomiting. Although vomiting is well controlled with the currently available non-cannabinoid antiemetics, nausea continues to be a distressing side effect of chemotherapy and other disorders. Indeed, when nausea becomes conditionally elicited by the cues associated with chemotherapy treatment, known as anticipatory nausea (AN), currently available antiemetics are largely ineffective. Considerable evidence demonstrates that the endocannabinoid system regulates nausea in humans and other animals. In this review, we describe recent evidence suggesting that cannabinoids and manipulations that enhance the functioning of the natural endocannabinoid system are promising treatments for both acute nausea and AN.
© 2015 Elsevier Inc. All rights reserved.

KEYWORDS:

2-Arachidonoylglycerol; Acute nausea; Anandamide; Anticipatory nausea; CB1; Endocannabinoid; Gaping; Illness

PMID:

 

26638766

 

[PubMed – in process]
twin memes II